were significantly correlated in a positive manner in the hippocampal region were as follows: GABA vs. Gln, and DA vs. 5-HT concentrations.
Abstract
Calcium dependent potassium channels are important for afterhyperpolarization in neurons and regulate the cellular excitability. Small conductance potassium (SK) channels are members of calcium-dependent potassium channels. Previous studies suggests potential involvement of the dysregulated SK2/3 functions in psychiatric disorders including schizophrenia (Ref. 1) . Because the functions of ion channels are generally regulated through reversible phosphorylation, albeit so far only a single domain of SK2/3 has been demonstrated as a clear target of phosphorylation (Ref.
2), we infer that multiple residues of SK2/3 undergo phosphorylation to control channels' function and such modification can be a target of pharmacological control for the disorders.
To achieve a comprehensive analysis of phosphorylationdependent SK channel regulation, we systematically induced phospho-mimetic mutations throughout the entire SK2 plypeptide. The series of mutants were analyzed in 293T cells by a new 384-well based screening assay, in which we took the advantage of fluorescent dyes and reverse transfection technique to simultaneous monitoring of mutants' channel activity. We discovered phsopho-mimetic mutants that either supress or enhance the channel activity. We are now trying to identify kinase(s) responsible for the phosphorylation on the mutated residues. Interstingly, we found several kinases that suppress SK channel activity when they are co-expressed with SK2 in 293T cells. These post-translational SK2 regulation could have a role in switching neuronal excitability, and its dysfunction may cause neurological disorders.
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Cholinergic Neurons in the Basal Forebrain Promote Wakefulness by Actions on Neighboring NonCholinergicNeurons: An Opto-Dialysis Study
Tae Kim, Kyung Hee University Hospital at Gangdong, Republic of Korea
Abstract Understanding the control of sleep-wake states by the basal forebrain (BF) poses a challenge due to the intermingled presence of cholinergic, GABAergic, and glutamatergic neurons. All three BF neuronal subtypes project to the cortex and are implicated in cortical arousal and sleep-wake control. Thus, nonspecific stimulation or inhibition studies do not reveal the roles of these different neuronal types. Recent studies using optogenetics have shown that "selective" stimulation of BF cholinergic neurons increasestransitions between NREM sleep and wakefulness, implicating cholinergic projections to cortex in wake promotion. However, the interpretation of these optogenetic experiments is complicated by interactions that may occur within the BF. For instance, a recent in vitro study found that cholinergic neurons strongly excite neighboring GABAergic neurons, including the subset of cortically projecting neurons, which contain the calcium-binding protein, parvalbumin (PV) (Yang et al., 2014). Thus, the wake-promoting effect of "selective" optogenetic stimulation of BF cholinergic neurons could be mediated by local excitation of GABA/PV or other non-cholinergic BF neurons. In this study, using a newly designed "optodialysis" probe to couple selective optical stimulation with simultaneousin vivomicrodialysis, we demonstrated that optical stimulation of cholinergic neurons locally increased acetylcholine levels and increased wakefulness in mice. Surprisingly, the enhanced wakefulness caused by cholinergic stimulation was abolished by simultaneous reverse microdialysis of cholinergic receptor antagonists into BF. Thus, our data suggest that the wake-promoting effect of cholinergic stimulation requires local release of acetylcholine in the basal forebrain and activation of cortically projecting, non-cholinergic neurons, including, but not limited to, the GABAergic/PV neurons.
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The effect of Yokukansan, a traditional herbal medicine, on sleep disturbances and anxiety symptoms in restless legs syndrome Abstract Objective: Dopaminergic agonists such as pramipexole are now considered the first-line treatment for restless legs syndrome (RLS). Dopaminergic agonist, however, sometimes fail to treat RLS. It is important to identify the factors that may prevent therapeutic agents from improving RLS symptoms. This study aims to examine whether anxiety symptoms affect the control of RLS symptoms in patients treated with pramipexole. We also investigated the effect of a herbal prescription, Yokukansan (YKS), on RLS and comorbid anxiety symptoms. Patients and Methods: Thirty-three patients with secondary RLS were enrolled in a prospective study. RLS symptoms and anxiety symptom were evaluated using the International RLS Study Group rating scale (IRLS) and Hamilton Anxiety Scale (HAM-A), respectively. Subjective sleep quality and daytime somnolence were also examined with Pittsburgh Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS), respectively. After being treated with pramipexole for 4 weeks, the subjects were divided into 2 groups based upon the IRLS score. The responder
